Dopaminergic agonists in animal models of parkinsonism.
D000661:Amphetamine / Q000627:therapeutic use; D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001058:Apomorphine / Q000627:therapeutic use; D002415:Cats; D004195:Disease Models, Animal; D000882:Haplorhini; D007980:Levodopa / Q000627:therapeutic use; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy*; D010891:Piribedil / Q000627:therapeutic use; D051381:Rats; D012110:Reserpine; D014443:Tyrosine / Q000031:analogs & derivatives
D000978:Antiparkinson Agents; D014443:Tyrosine; D007980:Levodopa; D012110:Reserpine; D000661:Amphetamine; D010891:Piribedil; D001058:Apomorphine